Oxford BioMedica PLC (OXB) — Strategic Asset Allocation Index
Oxford BioMedica PLC (OXB) has a Strategic Asset Allocation Index of 60.8% as of June 2023. Strategic assets (PP&E of GBX120.55 Million plus long-term investments of GBX-) total GBX120.55 Million, measured against net assets of GBX198.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Oxford BioMedica PLC balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Oxford BioMedica PLC Strategic Asset Allocation Index (2000–2021)
This chart shows how Oxford BioMedica PLC's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 60.8%, representing strategic assets of GBX120.55 Million against net assets of GBX198.16 Million GBX. For live market cap and overall valuation, see how much is Oxford BioMedica PLC worth.
Annual Strategic Asset Allocation Index for Oxford BioMedica PLC (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Oxford BioMedica PLC from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Oxford BioMedica PLC book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 37.2% | GBX69.73 Million | GBX69.73 Million | GBX- | GBX187.34 Million | ▼ -26.9 pp |
| 2020 | 64.1% | GBX72.30 Million | GBX72.30 Million | GBX- | GBX112.75 Million | ▼ -17.8 pp |
| 2019 | 81.9% | GBX61.93 Million | GBX61.93 Million | GBX- | GBX75.63 Million | ▼ -41.2 pp |
| 2018 | 123.1% | GBX42.76 Million | GBX31.79 Million | GBX10.97 Million | GBX34.74 Million | ▼ -337.8 pp |
| 2017 | 460.9% | GBX28.32 Million | GBX25.37 Million | GBX2.95 Million | GBX6.15 Million | ▲ +237.5 pp |
| 2016 | 223.3% | GBX28.17 Million | GBX27.51 Million | GBX657.00K | GBX12.62 Million | ▼ -0.6 pp |
| 2015 | 223.9% | GBX24.40 Million | GBX24.40 Million | GBX- | GBX10.89 Million | ▲ +185.1 pp |
| 2014 | 38.8% | GBX8.94 Million | GBX8.94 Million | GBX- | GBX23.04 Million | ▼ -6.9 pp |
| 2013 | 45.7% | GBX4.07 Million | GBX4.07 Million | GBX- | GBX8.90 Million | ▲ +25.9 pp |
| 2012 | 19.9% | GBX3.90 Million | GBX3.90 Million | GBX- | GBX19.64 Million | ▼ -3.8 pp |
| 2011 | 23.7% | GBX4.21 Million | GBX4.21 Million | GBX- | GBX17.77 Million | ▲ +18.7 pp |
| 2010 | 5.0% | GBX580.00K | GBX580.00K | GBX- | GBX11.61 Million | ▲ +2.0 pp |
| 2009 | 3.0% | GBX631.00K | GBX631.00K | GBX- | GBX20.98 Million | ▲ +0.1 pp |
| 2008 | 3.0% | GBX688.00K | GBX688.00K | GBX- | GBX23.27 Million | ▲ +0.4 pp |
| 2007 | 2.5% | GBX810.00K | GBX810.00K | GBX- | GBX31.93 Million | ▼ -0.2 pp |
| 2006 | 2.7% | GBX819.00K | GBX819.00K | GBX- | GBX30.09 Million | ▲ +0.9 pp |
| 2005 | 1.8% | GBX831.00K | GBX831.00K | GBX- | GBX46.60 Million | ▼ -2.9 pp |
| 2004 | 4.7% | GBX1.24 Million | GBX1.24 Million | GBX- | GBX26.38 Million | ▼ -1.9 pp |
| 2003 | 6.6% | GBX2.33 Million | GBX2.33 Million | GBX- | GBX35.21 Million | ▼ -6.7 pp |
| 2002 | 13.3% | GBX3.39 Million | GBX3.39 Million | GBX- | GBX25.53 Million | ▲ +3.6 pp |
| 2001 | 9.7% | GBX3.65 Million | GBX3.65 Million | GBX- | GBX37.51 Million | ▼ -0.3 pp |
| 2000 | 10.0% | GBX1.30 Million | GBX1.30 Million | GBX- | GBX12.98 Million | — |